U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 31 - 31 of 31 results

RUMEX CRISPUS WHOLE

MORE DETAILS

UQJ679MZAK

structurally diverse
Status:
Possibly Marketed Outside US
Source:
JEUNCELL a drug for atopic dermatitis by Jeun Cell Ltd
Source URL:
https://www.drugbank.ca/drugs/DB14267
First approved in 2012
Source:
JEUNCELL a drug for atopic dermatitis by Jeun Cell Ltd
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7934c32b-2806-40d8-b47a-bcdc5f7af085
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966